NCT03700983 is a NA clinical trial of Nutri-PEITC jelly in Head and Neck Cancer, sponsored by Dental Innovation Foundation Under Royal Patronage.

Who is sponsoring NCT03700983?

NCT03700983 is sponsored by Dental Innovation Foundation Under Royal Patronage.

What drugs are being tested in NCT03700983?

Interventions in NCT03700983: Nutri-PEITC jelly.

What condition does NCT03700983 study?

NCT03700983 studies Head and Neck Cancer.

Is NCT03700983 still recruiting?

NCT03700983 is currently completed. Last updated 9 October 2018.

Last reviewed 2018-10-09 · How we verify

NCT03700983

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pharmacokinetic Study of Nutri-PEITC Jelly in Head and Neck Cancer Survivors

Completed NA Last updated 9 October 2018

What this trial tests

NA trial testing Nutri-PEITC jelly in Head and Neck Cancer in 12 participants. Completed in 30 September 2018.

Timeline

6 August 2016

Primary endpoint
1 July 2018

30 September 2018

Quick facts

Lead sponsor	Dental Innovation Foundation Under Royal Patronage
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	12
Start date	6 August 2016
Primary completion	1 July 2018
Estimated completion	30 September 2018

Drugs / interventions tested

Nutri-PEITC jelly

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Dental Innovation Foundation Under Royal Patronage

Who can join

20 and older, any sex, with Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to evaluate the absorption and elimination profile of a bioactive compound PEITC in the matrix of Nutri-jelly - a novel edible nutritious gel. Thus, the investigators conducted a pharmacokinetic study in 12 head and neck cancer survivors. After consumed a serving of Nutri-jelly containing 20 mg PEITC, plasma levels of PEITC at 0, 1, 2, 3, 4, 6, 8, 12 and 24 hours were specifically measured by ammonia derivatization and analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). Non-compartmental pharmacokinetic analysis was performed.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling.
Koeberle SC, Kipp AP, Stuppner H, Koeberle A. · · 2023 · cited 74× · PMID 36658724 · DOI 10.1002/med.21933
Gain of Function (GOF) Mutant p53 in Cancer-Current Therapeutic Approaches.
Roszkowska KA, Piecuch A, Sady M, Gajewski Z, et al · · 2022 · cited 33× · PMID 36362074 · DOI 10.3390/ijms232113287

Verify or expand the search:

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other Dental Innovation Foundation Under Royal Patronage trials

Trials by the same sponsor.

NCT03035825 — Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03700983 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dental Innovation Foundation Under Royal Patronage
Last refreshed: 9 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03700983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing